Boston Scientific CorporationBSXNYSE
Loading
SG&A Expense Growth TrendStable
Percentile Rank93
3Y CAGR+40.3%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
+40.3%/yr
vs -10.2%/yr prior
Acceleration
+50.6pp
Accelerating
Percentile
P93
Near historical high
vs 3Y Ago
2.8x
Strong expansion
Streak
1 yr
Consecutive declineStable
PeriodValue
202515.09%
202415.30%
202314.82%
20225.46%
202113.18%
2020-3.59%
201910.43%
20188.41%
20176.42%
20168.29%